CI Systems (Israel) Ltd. (TLV:CISY)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,250.00
+49.00 (1.53%)
Jul 31, 2025, 5:24 PM IDT
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 0.8 | 0.34 | 5.05 | 4.35 | 1.12 | 0.96 | Upgrade |
Depreciation & Amortization | 1.17 | 1.13 | 1.03 | 0.8 | 0.75 | 0.03 | Upgrade |
Other Amortization | 0.11 | 0.11 | 0.09 | 0.04 | 0.03 | 0.76 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.05 | -0.03 | -0.04 | -0 | -0.02 | Upgrade |
Loss (Gain) From Sale of Investments | -0.16 | -0.14 | -0.08 | 0.43 | -0.15 | -0.12 | Upgrade |
Stock-Based Compensation | 0.04 | 0.05 | 0.08 | 0.11 | 0.01 | 0.03 | Upgrade |
Other Operating Activities | -0.04 | -0.01 | 0.04 | 0.56 | 0.13 | -0.1 | Upgrade |
Change in Accounts Receivable | -5.87 | -1 | 0.13 | -1.52 | -0.21 | 0.58 | Upgrade |
Change in Inventory | -3.46 | -2.74 | -1.52 | -2.99 | -0.84 | -0.19 | Upgrade |
Change in Accounts Payable | 0.62 | 0.76 | -0.15 | 0.01 | 0.71 | -0.49 | Upgrade |
Change in Unearned Revenue | 0.02 | 0.02 | 0.02 | 0.11 | 0.02 | 0.01 | Upgrade |
Change in Other Net Operating Assets | 1.68 | 0.08 | 1.14 | 0.55 | 0.18 | 0.96 | Upgrade |
Operating Cash Flow | -5.14 | -1.44 | 5.78 | 2.41 | 1.76 | 2.41 | Upgrade |
Operating Cash Flow Growth | - | - | 139.85% | 37.03% | -27.11% | 94.52% | Upgrade |
Capital Expenditures | -0.82 | -0.99 | -1.04 | -0.77 | -0.62 | -0.4 | Upgrade |
Sale of Property, Plant & Equipment | 0.13 | 0.14 | 0.1 | 0.11 | 0.15 | 0.1 | Upgrade |
Sale (Purchase) of Intangibles | -0.14 | -0.14 | -0.21 | -0.02 | -0.05 | -0 | Upgrade |
Investment in Securities | 5.53 | 2.9 | -2.9 | - | - | - | Upgrade |
Investing Cash Flow | 4.7 | 1.92 | -4.05 | -0.69 | -0.51 | -0.3 | Upgrade |
Long-Term Debt Repaid | - | -0.59 | -0.52 | -0.28 | -0.33 | -0.29 | Upgrade |
Net Debt Issued (Repaid) | -0.6 | -0.59 | -0.52 | -0.28 | -0.33 | -0.29 | Upgrade |
Repurchase of Common Stock | - | - | - | - | -0.01 | -0.05 | Upgrade |
Common Dividends Paid | -0.58 | -0.58 | -0.59 | -0.49 | -0.48 | - | Upgrade |
Other Financing Activities | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | -0.01 | Upgrade |
Financing Cash Flow | -1.19 | -1.18 | -1.14 | -0.8 | -0.84 | -0.34 | Upgrade |
Foreign Exchange Rate Adjustments | -0.04 | -0.05 | -0.08 | -0.14 | -0.16 | 0.24 | Upgrade |
Net Cash Flow | -1.67 | -0.75 | 0.52 | 0.79 | 0.24 | 2 | Upgrade |
Free Cash Flow | -5.96 | -2.43 | 4.74 | 1.64 | 1.14 | 2.01 | Upgrade |
Free Cash Flow Growth | - | - | 188.96% | 43.48% | -43.19% | 234.22% | Upgrade |
Free Cash Flow Margin | -16.55% | -7.23% | 12.88% | 4.66% | 4.36% | 8.18% | Upgrade |
Free Cash Flow Per Share | -0.57 | -0.22 | 0.43 | 0.15 | 0.11 | 0.19 | Upgrade |
Cash Interest Paid | 0.04 | 0.03 | 0.07 | 0.2 | 0.13 | 0.12 | Upgrade |
Cash Income Tax Paid | 0.59 | 0.58 | 0.7 | 0.28 | 0.29 | 0.23 | Upgrade |
Levered Free Cash Flow | -7.28 | -3 | 2.29 | -0.03 | 0.89 | 2.13 | Upgrade |
Unlevered Free Cash Flow | -7.2 | -2.9 | 2.29 | -0.01 | 1.02 | 2.29 | Upgrade |
Change in Net Working Capital | 7.98 | 3.24 | 0.76 | 3.49 | 0.12 | -1.07 | Upgrade |
Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.